Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -80.88% is 19% below its 5-year average of -67.76%, around the middle of its 5-year range (-103.60%–-42.39%).
As of the fiscal period ended Tuesday, June 30, 2026. 15.91% below its 12-month average of -69.78%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -80.88%.
RETURN ON INVESTED CAPITAL (ROIC)
-80.88%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-69.78%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-68.76%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-67.76%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-15.91%
CURRENT VS 3Y AVG
-17.63%
CURRENT VS 5Y AVG
-19.37%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-126.91%
vs the sector median at left
TELA Bio, Inc.
Market Cap
$48.99M
Return on Invested Capital (ROIC)
-80.88%
TTM Avg
-69.78%
3Y Avg
-68.76%
5Y Avg
-67.76%
Market Cap
$48.80M
Return on Invested Capital (ROIC)
-2441.49%
TTM Avg
-1590.42%
3Y Avg
-842.10%
5Y Avg
-573.16%
Market Cap
$49.25M
Return on Invested Capital (ROIC)
-14.57%
TTM Avg
-26.81%
3Y Avg
-19.60%
5Y Avg
-18.89%
Market Cap
$48.51M
Return on Invested Capital (ROIC)
-26.51%
TTM Avg
-172.21%
3Y Avg
-183.20%
5Y Avg
-141.01%
Market Cap
$49.58M
Return on Invested Capital (ROIC)
-96.37%
TTM Avg
-130.40%
3Y Avg
-89.09%
5Y Avg
-69.72%
Market Cap
$47.90M
Return on Invested Capital (ROIC)
-35.63%
TTM Avg
-5.31%
3Y Avg
3.75%
5Y Avg
-0.82%
Market Cap
$47.81M
Return on Invested Capital (ROIC)
-30.75%
TTM Avg
-66.28%
3Y Avg
-31.28%
5Y Avg
-35.56%
Market Cap
$50.72M
Return on Invested Capital (ROIC)
13.63%
TTM Avg
32.98%
3Y Avg
9.79%
5Y Avg
24.14%
Market Cap
$49.96M
Return on Invested Capital (ROIC)
-109.13%
TTM Avg
-196.06%
3Y Avg
-152.48%
5Y Avg
-122.21%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| TELA Bio, Inc. (TELA) | $48.99M | -80.88% | -69.78% | -68.76% | -67.76% |
| Apollomics, Inc. (APLM)vs › | $48.80M | -2441.49% | -1590.42% | -842.10% | -573.16% |
| Precision Optics Corporation, Inc. (POCI)vs › | $49.25M | -14.57% | -26.81% | -19.60% | -18.89% |
| Microbot Medical Inc. (MBOT)vs › | $48.51M | -26.51% | -172.21% | -183.20% | -141.01% |
| INmune Bio, Inc. (INMB)vs › | $49.58M | -96.37% | -130.40% | -89.09% | -69.72% |
| Sensus Healthcare, Inc. (SRTS)vs › | $47.90M | -35.63% | -5.31% | 3.75% | -0.82% |
| Lite Strategy, Inc. (LITS)vs › | $47.81M | -30.75% | -66.28% | -31.28% | -35.56% |
| biote Corp. (BTMD)vs › | $50.72M | 13.63% | 32.98% | 9.79% | 24.14% |
| Clene Inc. (CLNN)vs › | $49.96M | -109.13% | -196.06% | -152.48% | -122.21% |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $50.44M | -38.04% | -22.77% | -89.18% | -83.00% |
ROIC
-80.9%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -80.88% |
| 2026-03-31 | -64.29% |
| 2025-12-31 | -53.21% |
| 2025-09-30 | -78.57% |
| 2025-06-30 | -71.94% |
| 2025-03-31 | -64.92% |
| 2024-12-31 | -47.20% |
| 2024-09-30 | -103.60% |
| 2024-06-30 | -84.86% |
| 2024-03-31 | -65.79% |
| 2023-12-31 | -71.50% |
| 2023-09-30 | -57.29% |
| 2023-06-30 | -49.84% |
| 2023-03-31 | -91.07% |
| 2022-12-31 | -69.92% |
| 2022-09-30 | -57.84% |
| 2022-06-30 | -88.69% |
| 2022-03-31 | -74.36% |
| 2021-12-31 | -56.67% |
| 2021-09-30 | -48.03% |
| 2021-06-30 | -42.39% |
| 2021-03-31 | -35.83% |
| 2020-12-31 | -31.65% |
| 2020-09-30 | -27.99% |
| 2020-06-30 | -22.73% |
| 2020-03-31 | -37.50% |
| 2019-12-31 | -31.31% |
| 2019-09-30 | -112.50% |
| 2019-06-30 | -82.30% |
| 2018-12-31 | -100.65% |
